FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1565432734> ?p ?o ?g. }

• W1565432734 endingPage "E192" @default.
• W1565432734 startingPage "E183" @default.
• W1565432734 abstract "This study evaluates the cost-effectiveness of percutaneous cardiac assist device (pVAD) therapy in the emergent setting compared with traditional surgical hemodynamic support alternatives. Background: Previous research has demonstrated the cost-effectiveness of pVAD hemodynamic support for patients undergoing high-risk percutaneous coronary intervention. For patients in cardiogenic shock (CS), use of pVAD therapy has been shown to reduce length of stay (LOS). Methods: National utilization and outcome data from the 2010–2011 MedPAR and state-sponsored all-payer databases were collected for patients with an acute myocardial infarction complicated by CS who were treated with either a pVAD (n = 883) or with traditional surgical hemodynamic support alternatives (ECMO and extracorporeal VAD) (n = 305). Results: Discharge survival was greater with pVADs than with surgical alternatives (56% vs. 42%, P < 0.001) and was achieved with a strong trend toward reduced LOS (13.2 and 17.9 days, respectively, P = 0.055) and a significantly lower cost of the index admission ($90,929 and $144,257, respectively, P < 0.001). Cost-effectiveness analysis based on the national data demonstrated that pVAD achieved improved outcomes at lower cost. Data were also collected for similar patients who underwent protocol-guided pVAD therapy (using Impella 2.5) at PinnacleHealth, between 2009 and 2011 (n = 30). At this site, the survival rate increased to 60%, length of hospitalization was shortened to 6 days, and admission costs were lowered to $53,850 relative to the surgical alternatives strategy. Conclusions: For patients in CS requiring emergent hemodynamic support, pVAD therapy offers a less invasive alternative that can be deployed sooner, resulting in better outcomes, shorter LOS, lower costs and with no incremental cost, and a survival benefit when compared with traditional surgical hemodynamic support alternatives. PVAD therapy (and Impella 2.5 in particular) is emerging as a dominant strategy for this challenging patient population. © 2013 Wiley Periodicals, Inc." @default.
• W1565432734 created "2016-06-24" @default.
• W1565432734 creator A5002463774 @default.
• W1565432734 creator A5009763070 @default.
• W1565432734 creator A5045968773 @default.
• W1565432734 creator A5050540625 @default.
• W1565432734 date "2014-01-13" @default.
• W1565432734 modified "2023-09-30" @default.
• W1565432734 title "Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives" @default.
• W1565432734 cites W132261058 @default.
• W1565432734 cites W1505782299 @default.
• W1565432734 cites W1620735743 @default.
• W1565432734 cites W1972579249 @default.
• W1565432734 cites W1978699138 @default.
• W1565432734 cites W1986479972 @default.
• W1565432734 cites W1993057553 @default.
• W1565432734 cites W1997170099 @default.
• W1565432734 cites W2000589048 @default.
• W1565432734 cites W2007912847 @default.
• W1565432734 cites W2012154384 @default.
• W1565432734 cites W2012589941 @default.
• W1565432734 cites W2013612016 @default.
• W1565432734 cites W2022091748 @default.
• W1565432734 cites W2026141069 @default.
• W1565432734 cites W2038381502 @default.
• W1565432734 cites W2047386069 @default.
• W1565432734 cites W2048446504 @default.
• W1565432734 cites W2067508553 @default.
• W1565432734 cites W2069461010 @default.
• W1565432734 cites W2072737945 @default.
• W1565432734 cites W2080173813 @default.
• W1565432734 cites W2081745101 @default.
• W1565432734 cites W2085452873 @default.
• W1565432734 cites W2086940098 @default.
• W1565432734 cites W2105494662 @default.
• W1565432734 cites W2106703370 @default.
• W1565432734 cites W2108194485 @default.
• W1565432734 cites W2113291513 @default.
• W1565432734 cites W2113438941 @default.
• W1565432734 cites W2123748457 @default.
• W1565432734 cites W2132190220 @default.
• W1565432734 cites W2132734525 @default.
• W1565432734 cites W2138457421 @default.
• W1565432734 cites W2160025202 @default.
• W1565432734 cites W2161433125 @default.
• W1565432734 cites W2161601552 @default.
• W1565432734 cites W2165349656 @default.
• W1565432734 cites W2171424467 @default.
• W1565432734 cites W2239757471 @default.
• W1565432734 cites W2326536718 @default.
• W1565432734 cites W4206027652 @default.
• W1565432734 cites W4292329040 @default.
• W1565432734 doi "https://doi.org/10.1002/ccd.25247" @default.
• W1565432734 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24130115" @default.
• W1565432734 hasPublicationYear "2014" @default.
• W1565432734 type Work @default.
• W1565432734 sameAs 1565432734 @default.
• W1565432734 citedByCount "29" @default.
• W1565432734 countsByYear W15654327342015 @default.
• W1565432734 countsByYear W15654327342016 @default.
• W1565432734 countsByYear W15654327342017 @default.
• W1565432734 countsByYear W15654327342018 @default.
• W1565432734 countsByYear W15654327342019 @default.
• W1565432734 countsByYear W15654327342020 @default.
• W1565432734 countsByYear W15654327342021 @default.
• W1565432734 countsByYear W15654327342022 @default.
• W1565432734 countsByYear W15654327342023 @default.
• W1565432734 crossrefType "journal-article" @default.
• W1565432734 hasAuthorship W1565432734A5002463774 @default.
• W1565432734 hasAuthorship W1565432734A5009763070 @default.
• W1565432734 hasAuthorship W1565432734A5045968773 @default.
• W1565432734 hasAuthorship W1565432734A5050540625 @default.
• W1565432734 hasConcept C126322002 @default.
• W1565432734 hasConcept C164705383 @default.
• W1565432734 hasConcept C178853913 @default.
• W1565432734 hasConcept C194828623 @default.
• W1565432734 hasConcept C2776850375 @default.
• W1565432734 hasConcept C2778198053 @default.
• W1565432734 hasConcept C2778774980 @default.
• W1565432734 hasConcept C2780400711 @default.
• W1565432734 hasConcept C2780574415 @default.
• W1565432734 hasConcept C2780813298 @default.
• W1565432734 hasConcept C500558357 @default.
• W1565432734 hasConcept C71924100 @default.
• W1565432734 hasConceptScore W1565432734C126322002 @default.
• W1565432734 hasConceptScore W1565432734C164705383 @default.
• W1565432734 hasConceptScore W1565432734C178853913 @default.
• W1565432734 hasConceptScore W1565432734C194828623 @default.
• W1565432734 hasConceptScore W1565432734C2776850375 @default.
• W1565432734 hasConceptScore W1565432734C2778198053 @default.
• W1565432734 hasConceptScore W1565432734C2778774980 @default.
• W1565432734 hasConceptScore W1565432734C2780400711 @default.
• W1565432734 hasConceptScore W1565432734C2780574415 @default.
• W1565432734 hasConceptScore W1565432734C2780813298 @default.
• W1565432734 hasConceptScore W1565432734C500558357 @default.
• W1565432734 hasConceptScore W1565432734C71924100 @default.
• W1565432734 hasIssue "6" @default.
• W1565432734 hasLocation W15654327341 @default.

• next